Pfizer Stock Down After Announcing Mylan Deal

Pfizer Stock Down After Announcing Mylan Deal

Todd Peters, senior vice president at Adviser Investments, has the market analysis for Monday, July 29. U.S. indexes closed with mixed results: The Dow Jones Industrial Average rose 0.1% while the S&P 500 and NASDAQ Composite fell 0.1% and 0.4%, The Federal Reserve is set to cut rates for first time since 2008 in hopes of preventing a potential downturn in the economy. In the market, Pfizer’s stock announced merging its Upjohn business with Mylan. The stock was down 3% though, due to shortcomings in revenue estimates.

Recent Videos

View All Videos

2020 Conflicts: Impeachment, Tariffs & Global Dysfunction

Lowell on CNBC: Consumers Are the Backbone of the U.S. Economy

Lowell on CNBC: Election Biggest Unknown for Investors in 2020

Lowell on CNBC: Impeachment Not a Market Event (So Far)

85 Wells Avenue, Suite 109 Newton, MA, 02459

info@adviserinvestments.com 1.800.492.6868

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.